T
he World Health Organization defines adherence as Bthe extent to which a person's behavior-taking medication, following a diet, and/or executing lifestyle changes-corresponds with agreed recommendations from a health care provider.^While adherence research has focused primarily upon multiple dimensions related to taking medications in a manner congruent with prescriber recommendations, other aspects of the broader definition of adherence, including utilization of medical care and engagement in self-care behaviors, have received increasing attention in recent years. Moreover, with greater emphasis on patient-centered care and shared decision making between consumers of care and their health care provider(s), the pejorative term compliance has fallen out of favor and has been replaced nearly universally with the term adherence. Also, although adherence has traditionally focused upon medications used to manage long-term, chronic conditions (e.g., hypertension, diabetes, heart disease, rheumatic conditions), analogous principles are germane and have been applied to curable medical conditions (e.g., cancer, tuberculosis, hepatitis C virus infection).
Adherence, in the broadest context, is a well-recognized requirement for positive health outcomes for many medical conditions.
1 Longevity, quality of life, sustained presence in the workforce, and overall health are improved with adequate levels of adherence to, and persistence with, medication regimens and self-care behaviors for the management of medical conditions, including diabetes, asthma, hypertension, cancer, and HIV. 2 Despite the well-established benefits of persistent medication adherence, many people on long-term treatment for chronic conditions struggle to achieve or maintain high rates of adherence, with some rates as low as 6%. 3 Almost 50% of patients with chronic disease are not following the recommended medication treatment at 1 year after diagnosis. 4 This rate has shown very little change over the past three decades. Estimates of costs related to medication nonadherence are in the billions of dollars per year in the US alone. 4, 5 Not surprisingly, efforts to better understand the facilitators of, and barriers to, medication adherence have proliferated. As it relates to medication adherence, efforts to reduce toxicity, dosing burden, and demands of regimens have dramatically improved recommended courses of treatment. There remains, however, a significant need to optimize adherence for patients in the US. 6 A recent conference brought together providers, researchers, and industry representatives to examine patientcentered barriers to, and solutions for, improving medication adherence, including strategies for communicating with patients.
Current evidence regarding the efficacy of individual or combined interventions to improve adherence is mixed, 7 and new approaches for enhancing medication adherence are needed. We believe that it is time that adherence researchers start Bthinking outside the pill bottle.^Indeed, beyond medication adherence for chronic conditions, the adherence field has seen a renaissance in many disease areas, with extension of these principles to include congruence of patient behavior with recommended lifestyle modifications and self-care behaviors beyond medication taking. Understanding the multiple and multilevel factors that drive adherence behaviors, in the broader context, is essential to developing effective, patientcentered interventions to improve adherence and patient outcomes for both curable and chronic conditions.
In February 2016, The University of Alabama at Birmingham (UAB) hosted BInterdisciplinary Approaches to Understanding and Improving Adherence,^a cross-disciplinary meeting of numerous experts in adherence and adherence research, representing various medical specialties, scientific disciplines, and stakeholders from 12 institutions across the US. The goal of the meeting was to review the state-of-the-art in therapeutic and health care adherence research and identify research priorities based on key unanswered questions in the field. The attendees discussed current concepts in adherence research and clinical practice, and worked together to develop a research agenda that would move the field forward. Breakout sessions focused on adherence through the lens of health communications, health disparities, behavioral models and interventions, and pharmacoepidemiology and measurement. The articles that follow in this symposium were developed based on the discussions and plenary sessions at this meeting.
In BAdvancing the Science and Practice of Medication Adherence,^Stirratt and colleagues provide a review of adherence as a multidimensional construct with three components: initiation, implementation, and persistence. 8 These multiple adherence dimensions are dynamic, and in many cases function independently of one another. Adherence can be measured using various indirect and direct methods, each with their own advantages and disadvantages. The paper also describes several successful patient-, provider-, and systemslevel approaches to improving medication adherence. Finally, the paper lists key topics for future adherence research identified by the roundtable attendees.
McQuaid and Landier discuss the intersection of culture and medication adherence and the impact of poor medication adherence on health outcomes disparities in their paper BCultural Issues in Medication Adherence: Disparities and Directions.^9 Factors such as exposure to adversity and perceived discrimination can affect adherence to medications, as can cultural beliefs about the necessity of medication and participation in the health care system. The authors also discuss the impact of complementary and alternative medications and language barriers on adherence. The paper describes the role of the healthcare provider in acknowledging and discussing cultural issues with their patients and then implementing interventions to improve adherence in a culturally sensitive manner, and concludes with a list of key topics for ongoing adherence research utilizing culturally appropriate and effective communication and training at the patient, provider, and systems level.
In BAdvantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice,^Amico and colleagues review the contributions of social-behavioral science to developing comprehensive models and frameworks of adherence and the application of explanatory models to practice, research development, and scientific progress. 10 The authors argue that the act of taking a medication is only one part of achieving adherence, and a number of other factors affect medication taking that need to be considered in the realworld setting, such as the patient's acceptance of the condition, perception about the necessity of treatment, attitude toward the medication, and the ability to take the medication in a realworld setting. Social-behavioral models provide a framework that takes into account how these multilevel factors are necessary for rational development and testing of effective interventions to improve adherence. In this article, Amico and colleagues provide a review of social-behavioral models using examples from HIV medication adherence research, with the goal of demonstrating how these models can be used efficaciously in both clinical practice and research. They conclude with practical guidance on how to select, tailor, operationalize, and use a social-behavioral model of adherence.
Together, this collection of state-of-the-art papers provides an in-depth and multifaceted look at the current state of knowledge in medication adherence, the cultural considerations that shape patient and provider approaches to medication adherence, the social-behavioral models that can be applied to develop new interventions to improve medication adherence, and future directions in adherence research.
